Literature DB >> 1516434

Treatment of life-threatening primary pulmonary hemosiderosis with cyclophosphamide.

J L Colombo1, S M Stolz.   

Abstract

This report describes a five-year-old boy with severe pulmonary hemorrhage caused by primary pulmonary hemosiderosis with cow's milk sensitivity. After failing to respond to corticosteroids and azathioprine, he dramatically improved after being given cyclophosphamide. He worsened after discontinuation of cyclophosphamide on two occasions and improved significantly with its reinstitution. Cyclophosphamide was continued for 14 months without further bleeding or adverse effects. The patient has remained in remission for nearly five years. Cyclophosphamide may be a life-saving alternative therapy for refractory pulmonary hemorrhage with pulmonary hemosiderosis.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1516434     DOI: 10.1378/chest.102.3.959

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  4 in total

Review 1.  Proposed Pathogenesis of Diffuse Alveolar Hemorrhage in Idiopathic Pulmonary Hemosiderosis.

Authors:  Biplab K Saha; Woon H Chong; Santu Saha; Alexis Aiman; Alyssa Bonnier
Journal:  Lung       Date:  2022-03-10       Impact factor: 3.777

2.  Liposteroid against refractory pulmonary haemorrhage in idiopathic pulmonary haemosiderosis.

Authors:  S Ohga; A Nomura; N Suga; S Hikino; R Kira; A Matsuzaki; K Masuda; K Ueda
Journal:  Eur J Pediatr       Date:  1994-09       Impact factor: 3.183

3.  Rapidly progressive course of pauci-immune pulmonary capillaritis in a 70-year-old Asian male refractory to immunosuppression and plasma exchange.

Authors:  Chuan Jiang; Grace Nabila Martinez Pena; Meng Xie; Khalid Gafoor
Journal:  BMJ Case Rep       Date:  2020-03-12

4.  New insights into pediatric idiopathic pulmonary hemosiderosis: the French RespiRare(®) cohort.

Authors:  Jessica Taytard; Nadia Nathan; Jacques de Blic; Mickael Fayon; Ralph Epaud; Antoine Deschildre; Françoise Troussier; Marc Lubrano; Raphaël Chiron; Philippe Reix; Pierrick Cros; Malika Mahloul; Delphine Michon; Annick Clement; Harriet Corvol
Journal:  Orphanet J Rare Dis       Date:  2013-10-14       Impact factor: 4.303

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.